Beyond not bad or just okay: social predictors of young adults' wellbeing and functioning (a TRAILS study).


Journal

Psychological medicine
ISSN: 1469-8978
Titre abrégé: Psychol Med
Pays: England
ID NLM: 1254142

Informations de publication

Date de publication:
07 2019
Historique:
pubmed: 20 9 2018
medline: 1 5 2020
entrez: 20 9 2018
Statut: ppublish

Résumé

Various childhood social experiences have been reported to predict adult outcomes. However, it is unclear how different social contexts may influence each other's effects in the long run. This study examined the joint contribution of adolescent family and peer experiences to young adult wellbeing and functioning. Participants came from the TRacking Adolescents' Individual Lives Survey (TRAILS) study (n = 2230). We measured family and peer relations at ages 11 and 16 (i.e. family functioning, perceived parenting, peer status, peer relationship quality), and functioning as the combination of subjective wellbeing, physical and mental health, and socio-academic functioning at age 22. Using structural equation modelling, overall functioning was indicated by two latent variables for positive and negative functioning. Positive, negative and overall functioning at young adulthood were regressed on adolescent family experiences, peer experiences and interactions between the two. Family experiences during early and mid-adolescence were most predictive for later functioning; peer experiences did not independently predict functioning. Interactions between family and peer experiences showed that both protective and risk factors can have context-dependent effects, being exacerbated or overshadowed by negative experiences or buffered by positive experiences in other contexts. Overall the effect sizes were modest at best. Adolescent family relations as well as the interplay with peer experiences predict young adult functioning. This emphasizes the importance of considering the relative effects of one context in relation to the other.

Sections du résumé

BACKGROUND
Various childhood social experiences have been reported to predict adult outcomes. However, it is unclear how different social contexts may influence each other's effects in the long run. This study examined the joint contribution of adolescent family and peer experiences to young adult wellbeing and functioning.
METHODS
Participants came from the TRacking Adolescents' Individual Lives Survey (TRAILS) study (n = 2230). We measured family and peer relations at ages 11 and 16 (i.e. family functioning, perceived parenting, peer status, peer relationship quality), and functioning as the combination of subjective wellbeing, physical and mental health, and socio-academic functioning at age 22. Using structural equation modelling, overall functioning was indicated by two latent variables for positive and negative functioning. Positive, negative and overall functioning at young adulthood were regressed on adolescent family experiences, peer experiences and interactions between the two.
RESULTS
Family experiences during early and mid-adolescence were most predictive for later functioning; peer experiences did not independently predict functioning. Interactions between family and peer experiences showed that both protective and risk factors can have context-dependent effects, being exacerbated or overshadowed by negative experiences or buffered by positive experiences in other contexts. Overall the effect sizes were modest at best.
CONCLUSIONS
Adolescent family relations as well as the interplay with peer experiences predict young adult functioning. This emphasizes the importance of considering the relative effects of one context in relation to the other.

Identifiants

pubmed: 30229710
pii: S0033291718001976
doi: 10.1017/S0033291718001976
pmc: PMC6541871
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1459-1469

Références

Dev Psychol. 2014 Aug;50(8):2115-23
pubmed: 24932722
Child Dev. 2000 Jul-Aug;71(4):1072-85
pubmed: 11016567
J Abnorm Child Psychol. 2010 Jan;38(1):119-30
pubmed: 19707865
Eur Child Adolesc Psychiatry. 2015 Jul;24(7):815-26
pubmed: 25316094
J Adult Dev. 2010 Jun;17(2):110-119
pubmed: 20502508
Br J Psychiatry. 2015 Jun;206(6):456-60
pubmed: 25858180
J Am Acad Child Adolesc Psychiatry. 2012 Oct;51(10):1020-36
pubmed: 23021478
Child Psychiatry Hum Dev. 1993 Winter;24(2):67-80
pubmed: 8287694
J Youth Adolesc. 1992 Aug;21(4):471-85
pubmed: 24263975
Psychol Bull. 2006 Jan;132(1):98-131
pubmed: 16435959
J Adolesc. 2010 Apr;33(2):333-46
pubmed: 19716171
J Abnorm Child Psychol. 2006 Aug;34(4):509-26
pubmed: 16850285
Psychol Med. 2010 Sep;40(9):1507-18
pubmed: 19995477
J Abnorm Child Psychol. 2012 Nov;40(8):1249-64
pubmed: 22648200
Child Dev. 1992 Feb;63(1):103-15
pubmed: 1551320
PLoS One. 2014 Jul 21;9(7):e101751
pubmed: 25047692
Child Dev. 1996 Oct;67(5):2201-16
pubmed: 9022238
J Youth Adolesc. 2015 Sep;44(9):1752-66
pubmed: 25976526
Pers Individ Dif. 2012 May 1;52(7):800-805
pubmed: 22423172
J Genet Psychol. 2001 Dec;162(4):430-50
pubmed: 11831352
J Pers Soc Psychol. 1988 Jun;54(6):1063-70
pubmed: 3397865
Heredity (Edinb). 2005 Sep;95(3):221-7
pubmed: 16077740
J Am Acad Child Adolesc Psychiatry. 2016 Sep;55(9):771-83
pubmed: 27566118
Scand J Work Environ Health. 2005 Dec;31(6):438-49
pubmed: 16425585
Soc Psychiatry Psychiatr Epidemiol. 2015 Aug;50(8):1173-88
pubmed: 25861790
J Abnorm Child Psychol. 2010 Nov;38(8):1125-37
pubmed: 20532814
Soc Psychiatry Psychiatr Epidemiol. 2004 Apr;39(4):286-92
pubmed: 15085330
Int J Behav Dev. 2011 Nov;35(6):490-496
pubmed: 23372278
Soc Sci Med. 1997 Oct;45(7):1051-63
pubmed: 9257397
Soc Sci Med. 2000 Sep;51(6):843-57
pubmed: 10972429
Br J Psychiatry. 1985 Dec;147:598-611
pubmed: 3830321
Annu Rev Sociol. 2010 Aug 1;36:139-157
pubmed: 21921974
Dev Psychol. 2007 Nov;43(6):1484-1496
pubmed: 18020826
Psychol Bull. 1985 Sep;98(2):310-57
pubmed: 3901065
Dev Psychol. 2016 Dec;52(12):1969-1993
pubmed: 27893243
Int J Epidemiol. 2015 Feb;44(1):76-76n
pubmed: 25431468
J Res Adolesc. 2003 May 1;13(2):161-184
pubmed: 20209019
Am J Prev Med. 2012 Aug;43(2 Suppl 1):S8-S23
pubmed: 22789961
J Am Acad Child Adolesc Psychiatry. 2009 Mar;48(3):290-298
pubmed: 19182693
Dev Psychopathol. 2016 Aug;28(3):721-41
pubmed: 27427802
Psychometrika. 1950 Dec;15(4):349-67
pubmed: 14797902
Soc Sci Med. 2014 Mar;105:67-75
pubmed: 24508719
Health Aff (Millwood). 2007 Mar-Apr;26(2):549-58
pubmed: 17339685

Auteurs

J S Richards (JS)

University of Groningen, University Medical Center Groningen, Department of Psychiatry,Interdisciplinary Center Psychopathology and Emotion Regulation (ICPE),Groningen,The Netherlands.

C A Hartman (CA)

University of Groningen, University Medical Center Groningen, Department of Psychiatry,Interdisciplinary Center Psychopathology and Emotion Regulation (ICPE),Groningen,The Netherlands.

B F Jeronimus (BF)

University of Groningen, University Medical Center Groningen, Department of Psychiatry,Interdisciplinary Center Psychopathology and Emotion Regulation (ICPE),Groningen,The Netherlands.

J Ormel (J)

University of Groningen, University Medical Center Groningen, Department of Psychiatry,Interdisciplinary Center Psychopathology and Emotion Regulation (ICPE),Groningen,The Netherlands.

S A Reijneveld (SA)

University of Groningen, University Medical Center Groningen,Department of Health Sciences,Groningen,The Netherlands.

R Veenstra (R)

University of Groningen, Department of Sociology, Interuniversity Center for Social Science Theory and Methodology (ICS),Groningen,The Netherlands.

F C Verhulst (FC)

Erasmus University Medical Center Rotterdam,Department of Child Psychiatry/Psychology,Rotterdam,The Netherlands.

W A M Vollebergh (WAM)

Utrecht University,Department of Interdisciplinary Social Sciences,Utrecht,The Netherlands.

A J Oldehinkel (AJ)

University of Groningen, University Medical Center Groningen, Department of Psychiatry,Interdisciplinary Center Psychopathology and Emotion Regulation (ICPE),Groningen,The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH